Overcoming the low solubility of novel pyrazoloquinolinone ligand (CW-02-79) by combination of drug-phospholipid complex and nanoemulsion technology: design and physicochemical evaluation
Само за регистроване кориснике
2024
Аутори
Stanković, TijanaIlić, Tanja
Petković, Miloš
Pantelić, Ivana
Dobričić, Vladimir
Cook, James M.
Savić, Miroslav
Savić, Snežana
Остало (Објављена верзија)
Метаподаци
Приказ свих података о документуАпстракт
The low aqueous and oil solubility of the novelpyrazoloquinolinone ligand (CW-02-79) with significantbinding affinity for sigma-2 receptors in the brain hindersthe development of conventional parenteral formulationsand thus a comprehensive evaluation of its efficacy andsafety. ...
Кључне речи:
CW-02-79 / drug-phospholipid complex / nanoemulsion / pyrazoloquinolinoneИзвор:
2024Финансирање / пројекти:
- NanoCellEmoCog - Neuroimmune aspects of mood, anxiety and cognitive effects of leads/drug candidates acting at GABAA and/or sigma-2 receptors: In vitro/in vivo delineation by nano- and hiPSC-based platform (RS-ScienceFundRS-Ideje-7749108)
Напомена:
Повезане информације:
- Повезани садржај
https://farfar.pharmacy.bg.ac.rs/handle/123456789/5577
Институција/група
PharmacyTY - GEN AU - Stanković, Tijana AU - Ilić, Tanja AU - Petković, Miloš AU - Pantelić, Ivana AU - Dobričić, Vladimir AU - Cook, James M. AU - Savić, Miroslav AU - Savić, Snežana PY - 2024 UR - https://farfar.pharmacy.bg.ac.rs/handle/123456789/5578 AB - The low aqueous and oil solubility of the novelpyrazoloquinolinone ligand (CW-02-79) with significantbinding affinity for sigma-2 receptors in the brain hindersthe development of conventional parenteral formulationsand thus a comprehensive evaluation of its efficacy andsafety. ... T1 - Overcoming the low solubility of novel pyrazoloquinolinone ligand (CW-02-79) by combination of drug-phospholipid complex and nanoemulsion technology: design and physicochemical evaluation UR - https://hdl.handle.net/21.15107/rcub_farfar_5578 ER -
@misc{ author = "Stanković, Tijana and Ilić, Tanja and Petković, Miloš and Pantelić, Ivana and Dobričić, Vladimir and Cook, James M. and Savić, Miroslav and Savić, Snežana", year = "2024", abstract = "The low aqueous and oil solubility of the novelpyrazoloquinolinone ligand (CW-02-79) with significantbinding affinity for sigma-2 receptors in the brain hindersthe development of conventional parenteral formulationsand thus a comprehensive evaluation of its efficacy andsafety. ...", title = "Overcoming the low solubility of novel pyrazoloquinolinone ligand (CW-02-79) by combination of drug-phospholipid complex and nanoemulsion technology: design and physicochemical evaluation", url = "https://hdl.handle.net/21.15107/rcub_farfar_5578" }
Stanković, T., Ilić, T., Petković, M., Pantelić, I., Dobričić, V., Cook, J. M., Savić, M.,& Savić, S.. (2024). Overcoming the low solubility of novel pyrazoloquinolinone ligand (CW-02-79) by combination of drug-phospholipid complex and nanoemulsion technology: design and physicochemical evaluation. . https://hdl.handle.net/21.15107/rcub_farfar_5578
Stanković T, Ilić T, Petković M, Pantelić I, Dobričić V, Cook JM, Savić M, Savić S. Overcoming the low solubility of novel pyrazoloquinolinone ligand (CW-02-79) by combination of drug-phospholipid complex and nanoemulsion technology: design and physicochemical evaluation. 2024;. https://hdl.handle.net/21.15107/rcub_farfar_5578 .
Stanković, Tijana, Ilić, Tanja, Petković, Miloš, Pantelić, Ivana, Dobričić, Vladimir, Cook, James M., Savić, Miroslav, Savić, Snežana, "Overcoming the low solubility of novel pyrazoloquinolinone ligand (CW-02-79) by combination of drug-phospholipid complex and nanoemulsion technology: design and physicochemical evaluation" (2024), https://hdl.handle.net/21.15107/rcub_farfar_5578 .